P895: DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (D-VD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) ALONE IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED ANALYSIS OF LEPUS

• W. Fu,
• W. Li,
• J. Hu,
• G. An,
• Y. Wang,
• C. Fu,
• L. Chen,
• J. Jin,
• X. Cen,
• Z. Ge,
• Z. Cai,
• T. Niu,
• M. Qi,
• X. Gai,
• Q. Li,
• W. Liu,
• W. Liu,
• X. Yang,
• X. Chen,
• J. Lu

Affiliations

W. Fu

1 Shanghai Changzheng Hospital, Shanghai

W. Li

2 The First Hospital of Jilin University, Jilin

J. Hu

3 Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian

G. An

4 State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Y. Wang

5 Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin

C. Fu

6 The First Affiliated Hospital of Soochow University

L. Chen

7 The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Jiangsu

J. Jin

8 The First Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang

X. Cen

9 Peking University First Hospital, Beijing

Z. Ge

10 Zhongda Hospital Southeast University, Jiangsu

Z. Cai

8 The First Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang

T. Niu

11 Department of Hematology, West China Hospital Sichuan University, Sichuan, China

M. Qi

12 Janssen Research & Development, LLC, Spring House, PA, United States of America

X. Gai

13 Janssen Research & Development, LLC, Beijing

Q. Li

13 Janssen Research & Development, LLC, Beijing

W. Liu

14 Janssen Research & Development, LLC, Shanghai

W. Liu

13 Janssen Research & Development, LLC, Beijing

X. Yang

14 Janssen Research & Development, LLC, Shanghai

X. Chen

14 Janssen Research & Development, LLC, Shanghai

J. Lu

15 Peking University People’s Hospital, National Clinical Research Center for Hematologic Disease, Beijing